Penn Capital Management’s Artivion AORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$813K Buy
22,204
+6,333
+40% +$250K 0.06% 126
2025
Q4
$724K Buy
15,871
+169
+1% +$7.53K 0.06% 124
2025
Q3
$665K Sell
15,702
-555
-3% -$20.9K 0.05% 129
2025
Q2
$506K Sell
16,257
-3,105
-16% -$84K 0.04% 126
2025
Q1
$476K Buy
+19,362
New +$538K 0.05% 126
2024
Q2
Sell
-26,270
Closed -$556K 148
2024
Q1
$556K Buy
+26,270
New +$489K 0.05% 132
2023
Q4
Sell
-247,617
Closed -$3.75M 148
2023
Q3
$3.75M Buy
247,617
+36,793
+17% +$596K 0.38% 79
2023
Q2
$3.62M Buy
210,824
+156,244
+286% +$2.3M 0.35% 78
2023
Q1
$715K Buy
+54,580
New +$697K 0.07% 131
2022
Q4
Sell
-431,737
Closed -$5.98M 170
2022
Q3
$5.98M Sell
431,737
-178,798
-29% -$3.6M 0.67% 66
2022
Q2
$11.5M Buy
610,535
+59,680
+11% +$1.15M 1.24% 26
2022
Q1
$11M Buy
550,855
+151,505
+38% +$2.93M 1.13% 32
2021
Q4
$8.84M Sell
399,350
-2,546
-0.6% -$51.4K 0.89% 49
2021
Q3
$8.96M Buy
401,896
+122,272
+44% +$3.15M 0.9% 50
2021
Q2
$7.94M Sell
279,624
-135,299
-33% -$3.69M 0.77% 61
2021
Q1
$9.37M Buy
414,923
+7,473
+2% +$183K 0.98% 40
2020
Q4
$9.62M Sell
407,450
-119,781
-23% -$2.43M 1.22% 19
2020
Q3
$9.74M Buy
527,231
+163,666
+45% +$3.13M 1.23% 9
2020
Q2
$6.97M Buy
363,565
+187,712
+107% +$3.98M 0.91% 26
2020
Q1
$2.98M Buy
175,853
+4,847
+3% +$124K 0.49% 79
2019
Q4
$4.63M Buy
171,006
+109,986
+180% +$2.7M 0.49% 76
2019
Q3
$1.66M Buy
61,020
+285
+0.5% +$8.07K 0.17% 175
2019
Q2
$1.82M Hold
60,735
0.18% 156
2019
Q1
$1.77M Buy
60,735
+53,495
+739% +$1.53M 0.17% 154
2018
Q4
$205K Sell
7,240
-16,204
-69% -$487K 0.02% 223
2018
Q3
$825K Sell
23,444
-57,601
-71% -$1.86M 0.06% 217
2018
Q2
$2.26M Sell
81,045
-51
-0.1% -$1.29K 0.17% 152
2018
Q1
$1.63M Sell
81,096
-23,496
-22% -$449K 0.13% 180
2017
Q4
$2M Buy
104,592
+29,472
+39% +$590K 0.14% 170
2017
Q3
$1.71M Buy
+75,120
New +$1.51M 0.12% 181

Other funds holding AORT

Penn Capital Management's AORT Position: Q1 2026 in Review

Penn Capital Management increased its Artivion (AORT) stake by 40% in Q1 2026, buying an estimated $250K and bringing the position to 22,204 shares worth $813K. The position accounts for 0.06% of the portfolio, ranked #126.

Penn Capital Management first reported a position in AORT in Q3 2017 and has held it in 30 quarters since. The position peaked at $11.5M in Q2 2022. 239 funds tracked by Wall St. Rank hold AORT as of Q1 2026.

  • Penn Capital Management held 22,204 shares of Artivion worth $813K as of Q1 2026.
  • Penn Capital Management bought 6,333 Artivion shares in Q1 2026, an estimated $250K.
  • Artivion made up 0.06% of Penn Capital Management's portfolio in Q1 2026, its #126 holding.
  • Penn Capital Management first reported a position in Artivion in Q3 2017 and has held it in 30 quarters since.
  • Penn Capital Management's Artivion position peaked at $11.5M in Q2 2022.
  • 239 funds tracked by Wall St. Rank held Artivion as of Q1 2026.

Based on Penn Capital Management's 13F filing for Q1 2026, filed 7 May 2026.